250 related articles for article (PubMed ID: 16990356)
1. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases.
Senzaki H
Arch Dis Child; 2006 Oct; 91(10):847-51. PubMed ID: 16990356
[TBL] [Abstract][Full Text] [Related]
2. Elastolytic matrix metalloproteinases and coronary outcome in children with Kawasaki disease.
Lau AC; Rosenberg H; Duong TT; McCrindle BW; Yeung RS
Pediatr Res; 2007 Jun; 61(6):710-5. PubMed ID: 17426658
[TBL] [Abstract][Full Text] [Related]
3. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.
Gavin PJ; Crawford SE; Shulman ST; Garcia FL; Rowley AH
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):576-81. PubMed ID: 12692003
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
5. [Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease].
Chen R; Zhang AR; Zhao XX; Li ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):989-91. PubMed ID: 20113606
[TBL] [Abstract][Full Text] [Related]
6. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease.
Senzaki H; Masutani S; Kobayashi J; Kobayashi T; Nakano H; Nagasaka H; Sasaki N; Asano H; Kyo S; Yokote Y
Circulation; 2001 Aug; 104(8):860-3. PubMed ID: 11514369
[TBL] [Abstract][Full Text] [Related]
7. [Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms].
Caballero-Mora FJ; Alonso-Martín B; Tamariz-Martel-Moreno A; Cano-Fernández J; Sánchez-Bayle M
An Pediatr (Barc); 2011 Apr; 74(4):232-8. PubMed ID: 21296631
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[TBL] [Abstract][Full Text] [Related]
9. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.
Korematsu S; Ohta Y; Tamai N; Takeguchi M; Goto C; Miyahara H; Kawano T; Izumi T
Pediatr Infect Dis J; 2012 Sep; 31(9):973-4. PubMed ID: 22895216
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
[TBL] [Abstract][Full Text] [Related]
11. Sudden death caused by coronary artery aneurysms: a late complication of Kawasaki disease.
Wreford FS; Conradi SE; Cohle SD; Lie JT; Dana SE; Puri S
J Forensic Sci; 1991 Jan; 36(1):51-9. PubMed ID: 2007880
[TBL] [Abstract][Full Text] [Related]
12. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
Chaker L; Drissa MA; Drissa H
Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
[No Abstract] [Full Text] [Related]
13. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC; Aronoff SC
Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
[TBL] [Abstract][Full Text] [Related]
14. [Kawasaki disease: heart disease during childhood].
Schroh AM; Domínguez P; Laghezza LB; Melonari PA; Olguín M; Miatello R
Rev Esp Cardiol; 2006 Apr; 59(4):387-90. PubMed ID: 16709393
[TBL] [Abstract][Full Text] [Related]
15. [Acute myocardial infarction in a young adult with multiple coronary aneurysms resulting form Kawasaki disease].
Crepaz R; Pitscheider W; Erlicher A; Zammarchi A; Braito E
G Ital Cardiol; 1993 Jun; 23(6):589-93. PubMed ID: 8405821
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy.
Senzaki H; Kobayashi T; Nagasaka H; Nakano H; Kyo S; Yokote Y; Sasakid N
Pediatr Res; 2003 Jun; 53(6):983-8. PubMed ID: 12621103
[TBL] [Abstract][Full Text] [Related]
17. Giant coronary aneurysms in a young adult patient with Kawasaki disease.
Canino-Rodríguez A; Cox RA
P R Health Sci J; 2008 Dec; 27(4):382-6. PubMed ID: 19069372
[TBL] [Abstract][Full Text] [Related]
18. Severe triple vessel coronary artery disease and aneurysms in a young white man: disease progression of childhood Kawasaki disease.
Sivalingam SK; Parthasarathy HK; Choong CK; Freeman LJ
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):170-3. PubMed ID: 19194177
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of coronary artery aneurysms in a child with Kawasaki disease.
Bisset GS; Strife JL; McCloskey J
AJR Am J Roentgenol; 1989 Apr; 152(4):805-7. PubMed ID: 2784264
[No Abstract] [Full Text] [Related]
20. Coronary artery bypass grafting in an adult case with Kawasaki disease.
Hayashida N; Tayama E; Teshima H; Kawara T; Aoyagi S
Ann Thorac Cardiovasc Surg; 2002 Feb; 8(1):47-50. PubMed ID: 11916444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
